01 1Viatris
01 1ELETRIPTAN HYDROBROMIDE (PROCESS 1)
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-20
Pay. Date : 2012-11-07
DMF Number : 24504
Submission : 2010-12-28
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELETRIPTAN HYDROBROMIDE (PROCESS 1), with a corresponding US DMF Number 24504.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 20, 2013, and payment made on November 07, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
